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IMPORTANCE The Enhanced Recovery After Surgery (ERAS) care protocol has been shown to
improve outcomes compared with traditional care in certain types of surgery.
OBJECTIVE To assess the association of use of the ERAS protocols with complications in
patients undergoing elective total hip arthroplasty (THA) and total knee arthroplasty (TKA).
DESIGN, SETTING, AND PARTICIPANTS This multicenter, prospective cohort study included
patients recruited from 131 centers in Spain from October 22 through December 22, 2018.
All consecutive adults scheduled for elective THA or TKA were eligible for inclusion. Patients
were stratified between those treated in a self-designated ERAS center (ERAS group) and
those treated in a non-ERAS center (non-ERAS group). Data were analyzed from June 15
through September 15, 2019.
EXPOSURES Total hip or knee arthroplasty and perioperative management. Sixteen individual
ERAS items were assessed in all included patients, whether they were treated at a center that
was part of an established ERAS protocol or not.
MAIN OUTCOMES AND MEASURES The primary outcome was postoperative complications
within 30 days after surgery. Secondary outcomes included length of stay and mortality.
RESULTS During the 2-month recruitment period, 6146 patients were included (3580 women
[58.2%]; median age, 71 [interquartile range (IQR), 63-76] years). Of these, 680 patients
(11.1%) presented with postoperative complications. No differences were found in the
number of patients with overall postoperative complications between ERAS and non-ERAS
groups (163 [10.2%] vs 517 [11.4%]; odds ratio [OR], 0.89; 95% CI, 0.74-1.07; P = .22). Fewer
patients in the ERAS group had moderate to severe complications (73 [4.6%] vs 279 [6.1%];
OR, 0.74; 95% CI, 0.56-0.96; P = .02). The median overall adherence rate with the ERAS
protocol was 50.0% (IQR, 43.8%-62.5%), with the rate for ERAS facilities being 68.8%
(IQR, 56.2%-81.2%) vs 50.0% (IQR, 37.5%-56.2%) at non-ERAS centers (P < .001). Among
the patients with the highest and lowest quartiles of adherence to ERAS components,
the patients with the highest adherence had fewer overall postoperative complications
(144 [10.6%] vs 270 [13.0%]; OR, 0.80; 95% CI, 0.64-0.99; P < .001) and moderate to
severe postoperative complications (59 [4.4%] vs 143 [6.9%]; OR, 0.62; 95% CI, 0.45-0.84;
P < .001) and shorter median length of hospital stay (4 [IQR, 3-5] vs 5 [IQR, 4-6] days; OR,
0.97; 95% CI, 0.96-0.99; P < .001).
CONCLUSIONS AND RELEVANCE An increase in adherence to the ERAS program was associated
with a decrease in postoperative complications, although only a few ERAS items were
individually associated with improved outcomes.
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A n estimated 310 million patients undergo surgery world-wide each year.1 In the United States, 1 million total hiparthroplasty (THA) and total knee arthroplasty (TKA)
procedures are performed annually, with an expectation of
growth in the coming years.2 The International Surgical Out-
comes Study3 showed that 16.5% of patients who underwent
orthopedic surgery experienced complications. The inci-
dence of complications in THA and TKA was 3.2% to 8.0%,4
with an important variability between centers.4,5 Postopera-
tive complications after THA and TKA have been shown to in-
crease hospital length of stay (LOS).6 Kehlet7 described the con-
cept of the multimodal approach to recovery in 1997. The
Enhanced Recovery After Surgery (ERAS) program that en-
tails an evidenced-based protocol based on a wide literature
search was initiated by Ljungqvist et al8 in the ERAS study
group, which later developed into the ERAS Society. The
ERAS protocol includes a variable number of multidisci-
plinary perioperative measures whose initial goal is to im-
prove recovery and reduce morbidity, which will result in sec-
ondary benefits, including reductions in LOS, convalescence,
and costs.9 Observational studies10 and randomized clinical
trials11 have shown that ERAS was associated with improved
outcomes in patients undergoing THA and TKA, mainly a de-
crease in LOS.12,13
Until the recent publication of the ERAS Society THA and
TKA guidelines,14 the most accepted recommendations were
those proposed by Soffin and YaDeau in 2016.15 ERAS in THA
and TKA share the same problems as ERAS in other surgical
procedures: adoption is slow,16 and adherence to ERAS guide-
lines is low.17
The aim of this study was to characterize the management
strategies for patients who underwent elective THA or TKA, in-
cluding centers with and without an established ERAS proto-
col. The primary end point was the incidence of postoperative
complications. Secondary end points were LOS and the poten-
tial associations between the adherence to the individual ERAS
items and the occurrence of postoperative complications.
Methods
Study Design and Participants
This study is reported in accordance with the Strengthening
the Reporting of Observational Studies in Epidemiology
(STROBE) reporting guideline18 and the Reporting on ERAS
Compliance, Outcomes, and Elements Research (RECOVER)
Checklist.19 Hospital and investigator engagement was
facilitated through the Spanish Perioperative Audit and
Research Network (REDGERM), which was established by the
Grupo Español de Rehabilitación Multimodal (GERM). All
hospitals in Spain were invited to participate regardless of the
number of beds and the existence of an ERAS protocol.
The Postoperative Outcomes Within Enhanced Recovery
After Surgery Protocol in Elective Total Hip and Knee Arthro-
plasty (POWER2) study was a prospective 2-month multi-
center cohort study. The study was approved by the Instituto
Aragonés de Ciencias de la Salud Ethics Committee, Zara-
goza, Spain, and the Spanish Medical Agency and was regis-
tered prospectively in an international trial registry.20 The study
protocol, technical appendix, and other documents are avail-
able at http://www.grupogerm.es/power2, and the study pro-
tocol has been published.21
The ethics committees or institutional review boards at
each site reviewed and approved the protocol. Written in-
formed consent was obtained from all participants.
Procedures
All consecutive adult patients (aged >18 years) undergoing elec-
tive primary THA or TKA were included during a single pe-
riod of recruitment from October 22 through December 22,
2018, in each participating center. Each patient was followed
up for 30 days after surgery. The follow-up was performed
through hospital and primary care medical records.
Data were collected using Castor Electronic Data Capture22
and anonymized before entry onto a secure Internet-based
electronic case record form designed specifically for POWER2.
Participating hospitals were considered self-proclaimed ERAS
centers in cases in which a multidisciplinary clinical pathway
was implemented, regardless of the perioperative items that
conformed to the pathway and whether hospitals were au-
dited regularly. Individual data on 16 ERAS items were col-
lected prospectively for each included patient. The definition
of the individual ERAS components was based on the recom-
mendations of Soffin and YaDeau15 (eTable 1 in the Supple-
ment). Data included patient characteristics (American Soci-
ety of Anesthesiologists [ASA] score, age, sex, smoking status,
body mass index, clinical frailty score, and comorbidities), pro-
cedure performed, surgical approach, perioperative interven-
tions, adherence to ERAS items, and outcomes (including post-
operative complications, time to achieve targeted mobility,
LOS, and 30-day mortality). Complications were defined and
graded as mild, moderate, or severe according to interna-
tional recommendations21,23-26 (eTable 2 in the Supplement)
and were included if they occurred within 30 days after sur-
gery. Data validation was conducted by specific validators at
each site. A minimum sample size of 3012 was estimated, ex-
pecting 50% of patients with at least 1 complication, a 95% con-
fidence level, and 3% accuracy.
Key Points
Question How frequent are complications after total hip and knee
arthroplasty procedures and how are the Enhanced Recovery
After Surgery (ERAS) protocols associated with them?
Findings In this large, multicenter cohort study that included
6146 patients in 131 hospitals, 680 (11.1%) presented with
postoperative complications and 352 (5.7%) presented with
complications graded as moderate to severe. Patients who had
greater compliance with the ERAS items had fewer postoperative
complications, regardless of whether or not the center had an
established ERAS protocol.
Meaning Although only a few perioperative interventions were
associated with decreased complications, greater adherence with
the set of ERAS measures was associated with a decrease in
postoperative complications at 30 days of follow-up.
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Outcomes
The primary outcome was the number of patients with 30-
day in-hospital postoperative complications. Secondary out-
come measures included the number of patients with 30-day
in-hospital postoperative moderate to severe complications,
mortality, readmission, reintervention rates, and hospital LOS.
Statistical Analysis
Data were analyzed from March 15 through September 15,
2019. We analyzed outcomes depending on whether the
patient received treatment at a hospital that belonged to a self-
designated ERAS program (ERAS group). The discrete and con-
tinuous variables were described as number (percentage) and
median (interquartile range [IQR]), respectively. We analyzed
differences using the Fisher exact test for discrete variables and
the Pearson and Wilcoxon rank sum tests for continuous vari-
ables. Subsequently, we repeated the analysis, subdividing the
sample into quartiles according to the real adherence rate to
ERAS items (regardless of whether the patient was treated at
an ERAS hospital or not) and comparing the quartiles of higher
and lower adherence to ERAS items. Next, we analyzed com-
plication rates for each of the ERAS items using the Fisher ex-
act test, and we performed a multivariable logistic regression
analysis to study the association of the rate of each of the items
with the clinical and demographic variables. We also used the
same model in a multilevel multivariable logistic regression
model to explore independent factors associated with post-
operative complications assessing the variability of each site.
Stratification by type of surgery (THA or TKA) was performed
for the most relevant outcomes.
We performed several post hoc analyses. To assess the as-
sociation of the underlying pathologic finding in the in-
cluded patients, we divided the patients between those with
ASA scores of I through II and III through IV (higher scores in-
dicate severe preoperative systemic disease) and analyzed the
adherence to ERAS items in these groups, as well as the post-
operative outcomes. We performed this analysis for the self-
described ERAS centers vs non-ERAS centers and for the ERAS
adherence quartiles, depending on the median compliance in
each group. Bubble plots were used to graphically illustrate the
associations between the percentage of patients with postop-
erative complications and LOS with the volume of patients re-
cruited at each site. To study the association between the per-
centage of patients with postoperative complications and LOS
and the volume of patients recruited by each center, we used
2 β regression models. Through a linear regression model,
we performed a post hoc analysis to evaluate the influence of
ERAS items and other perioperative variables in LOS. For
this purpose, we performed a univariable and a multivariable
analysis. We denoted as statistically significant those com-
parisons where 2-sided P < .05.
Results
Participants
Data describing 6146 patients were collected in 131 hospitals
in Spain (Figure 1). Of these, 2566 (41.8%) were men and
3580 were women (58.2%); median age was 71 (IQR, 63-76)
years. Other characteristics are shown in Table 1. No centers
or patients were excluded owing to low recruitment. Accord-
ing to the hospitals where the surgeries were performed, 1592
patients (25.9%) were included in self-designated ERAS cen-
ters. The ERAS and non-ERAS groups showed demographic
differences in the number of patients with hypertension
(2747 [60.3%] vs 900 [56.5%]), coronary artery disease (290
[6.4%] vs 70 [4.4%]), atrial fibrillation (336 [7.4%] vs 85
[5.3%]), chronic kidney disease (224 [4.9%] vs 108 [6.8%]),
ASA score (ASA III-IV (345 [21.7%] vs 1273 [28.0%]), and dura-
tion of surgery (median, 90 [IQR, 75-115] vs 83 [IQR, 65-104]
minutes). More patients in the ERAS group received local
anesthesia (188 [11.8%] vs 64 [1.4%]) and tranexamic acid
(1348 [85.9%] vs 3191 [70.2%]), whereas fewer patients in the
ERAS group received epidural (38 [2.4%] vs 350 [7.7%]) or
regional (157 [9.9%] vs 770 [16.9%]) anesthesia. Patients in
the ERAS group also received fewer crystalloids (median,
800 [IQR, 550-1000] vs 1000 [IQR, 700-1200] mL) and col-
loids (median, 0 [IQR, 0-250] vs 0 [IQR, 0-0] mL) during sur-
gery as well as fewer red blood cell transfusions (RBCTs)
(mean [SD], 9 [0.6%] vs 52 [1.1%]) (Table 1). ERAS adherence
quartiles were calculated for all patients from the median
overall adherence to the 16 ERAS items, regardless of
whether the patient was treated within an ERAS protocol.
Adherence in quartile 1 was 43.75% or less; in quartile 2, greater
than 43.75% to 50.00%; in quartile 3, greater than 50.00% to
62.50%; and in quartile 4, greater than 62.50%. The quartile
with the lowest adherence to ERAS included the most pa-
tients (eTable 3 in the Supplement). Patients with lower ad-
herence to ERAS had a higher prevalence of chronic kidney
disease (48 [4.4%] vs 103 [5.0%]), had longer duration of sur-
gery (median, 90 [IQR, 74-110] vs 90 [IQR, 75-115] minutes),
received more crystalloid during surgery (median, 1000
[IQR, 700-1200] vs 1000 [750-1200] mL), and had more
epidural anesthesia (73 [6.8%] vs 149 [7.2%]) and regional an-
algesia (185 [17.1%] vs 244 [11.8%]) performed compared with
the group with greater adherence to ERAS (eTable 3 in the
Supplement).
Figure 1. STROBE Flow Diagram for Included Patients
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Age, median (IQR), y 71 (63-76) 71 (64-76) 70 (63-76)
Men 2566 (41.8) 1904 (41.8) 662 (41.6)
BMI, median (IQR) 29.3 (26.4-32.9) 29.4 (26.4-32.8) 29.3 (26.4-32.9)
ASA classificationb
ASA I 391 (6.4) 262 (5.8) 129 (8.1)
ASA II 4136 (67.3) 3019 (66.3) 1117 (70.2)
ASA III 1575 (25.6) 1238 (27.2) 337 (21.2)
ASA I-II 4257 (73.7) 3281 (72.0) 1246 (78.3)
ASA III-IV 1618 (26.3) 1273 (28.0) 345 (21.7)
Former smoker 1005 (16.4) 758 (16.6) 247 (15.5)
Current smoker 699 (11.4) 505 (11.1) 194 (12.2)
Frailty score, median (IQR)c 3 (2-3) 3 (2-3) 3 (2-4)
Hypertension 3647 (59.3) 2747 (60.3) 900 (56.5)
Diabetes 1140 (18.5) 848 (18.6) 292 (18.3)
Coronary arterial disease 360 (5.9) 290 (6.4) 70 (4.4)
Heart failure 158 (2.6) 113 (2.5) 45 (2.8)
Cirrhosis 52 (0.8) 42 (0.9) 10 (0.6)
Stroke 288 (4.7) 226 (5.0) 62 (3.9)
Atrial fibrillation 421 (6.8) 336 (7.4) 85 (5.3)
COPD/asthma 694 (11.3) 522 (11.5) 172 (10.8)
Chronic kidney disease 332 (5.4) 224 (4.9) 108 (6.8)
Peripheral vasculopathy 281 (4.6) 217 (4.8) 64 (4.0)
Rheumatoid arthritis 126 (2.1) 94 (2.1) 32 (2.0)
Dementia 66 (1.1) 55 (1.2) 11 (0.7)
Hemoglobin level, median (IQR), g/dL 14.0 (13.1-15.0) 14.1 (13.1-15.0) 14.0 (13.1-15.0)
Creatinine level, median (IQR), mg/dL 0.80 (0.70-0.95) 0.80 (0.69-0.95) 0.80 (0.70-0.96)
THA 2301 (37.4) 1711 (37.6) 590 (37.1)
TKA 3845 (62.6) 2843 (62.4) 1002 (62.9)
Duration of surgery, median (IQR), min 90 (75-110) 90 (75-115) 83 (65-104)
Anesthesia
General 460 (7.5) 351 (7.7) 109 (6.8)
Intradural 5679 (92.4) 4202 (92.3) 1477 (92.8)
Epidural 388 (6.3) 350 (7.7) 38 (2.4)
Regional 927 (15.1) 770 (16.9) 157 (9.9)
Local 252 (4.1) 64 (1.4) 188 (11.8)
Crystalloid administered, median (IQR), mL 1000 (700-1200) 1000 (700-1200) 800 (550-1000)
Colloid administered, median (IQR), mL 0 (0-0) 0 (0-0) 0 (0-250)
Red blood cell transfusion 61 (1.0) 52 (1.1) 9 (0.6)
Red blood cell transfused, median (IQR), mL 445 (260-560) 400 (258-500) 715 (525-800)
Blood loss, median (IQR), mL 200 (100-350) 200 (100-350) 200 (100-400)
Tranexamic acid administered 4539 (73.9) 3191 (70.2) 1348 (85.9)
Presurgical education 1688 (27.5) 433 (9.5) 1255 (78.8)
Presurgical optimization 1193 (19.4) 547 (12.0) 646 (40.6)
Preoperative fasting 2997 (48.8) 1831 (40.2) 1166 (73.2)
Patient blood management 2396 (39.0) 1273 (28.0) 1123 (70.5)
Preoperative carbohydrate drinks preload 117 (1.9) 78 (1.7) 39 (2.4)
Avoidance of long-acting sedative premedication 3311 (53.9) 2448 (53.8) 863 (54.2)
Thromboprophylaxis 5655 (92.0) 4120 (90.5) 1535 (96.4)
Antibiotic prophylaxis 6076 (98.9) 4497 (98.7) 1579 (99.2)
Regional anesthesia 4919 (80.0) 3575 (78.5) 1344 (84.4)
(continued)
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Outcome Data
A total of 680 patients (11.1%) experienced overall postopera-
tive complications, and 352 (5.7%) experienced complica-
tions graded as moderate to severe (eFigure 1 in the Supple-
ment). No differences were found in the number of patients
with overall postoperative complications between the ERAS
and non-ERAS groups (163 [10.2%] vs 517 [11.4%]; OR, 0.89;
95% CI, 0.74-1.07; P = .22) or in terms of readmission, reinter-
vention, or survival (eFigure 1 in the Supplement). Fewer pa-
tients in the ERAS group had moderate to severe complica-
tions (73 [4.6%] vs 279 [6.1%]; OR, 0.74; 95% CI, 0.56-0.96;
P = .02). eTables 4 and 5 in the Supplement show the strati-
fied complications in THA and TKA in ERAS vs non-ERAS cen-
ters. In THA and TKA, the ERAS group had shorter median LOS
(THA, 4 [IQR, 3-5] vs 5 [IQR, 4-6] days; TKA, 4 [IQR, 3-5] vs
5 [IQR, 4-6] days) (eFigure 1 and eTables 4 and 5 in the Supple-
ment). Graduation of the severity of postoperative complica-
tions is shown in eTable 6 of the Supplement.
ERAS Adherence and Outcome Data
The overall adherence rate to the ERAS protocol components
was 50.0% (IQR, 43.8%-62.5%), with the rate for ERAS facili-
ties being 68.8% (IQR, 56.2%-81.2%) vs 50.0% (IQR, 37.5%-
56.2%) at non-ERAS centers (P < .001). Adherence to specific
ERAS items was greater in the ERAS group (Table 1). The ERAS
group also had less bleeding (median blood loss, 200 [IQR, 100-
400] vs 200 [IQR, 100-350] mL), less use of intraoperative crys-
talloids (median, 800 [IQR, 550-100] vs 1000 [IQR, 700-
1200] mL), and greater intraoperative administration of
tranexamic acid (1348 [85.9%] vs 3191 [70.2%]) (Table 1). In the
TKA and THA procedures, adherence to perioperative ERAS
items was greater in the ERAS group (eTables 7, 8, and 9 in the
Supplement).
Patients in the ERAS group undergoing THA and TKA had
less time to ambulation (mean [SD] for THA, 17.2 [13.3] vs 30.9
[24.4] hours; mean [SD] for TKA, 15.2 [13.9] vs 29.1 [15.5] hours)
and oral intake (mean [SD] for THA, 6.04 [5.12] vs 8.12 [11.2]
hours; mean [SD] for TKA, 6.05 [5.11] vs 8.20 [6.07] hours)
(eTable 10 in the Supplement). Among the highest (quartile 4)
and lowest (quartile 1) quartiles of adherence to ERAS items,
quartile 4 also had a decrease in the rate of overall postopera-
tive complications (270 [13.0%] vs 144 [10.6%]; OR, 0.80; 95%
CI, 0.64-0.99; P < .001), moderate to severe postoperative com-
plications (143 [6.9%] vs 59 [4.4%]; OR, 0.62; 95%, CI, 0.45-
0.84; P < .001), postoperative hemorrhage (106 [5.1%] vs 31
[2.3%]; OR, 0.44; 95% CI, 0.29-0.65; P < .001), infection of un-
certain source (17 [0.8%] vs 3 [0.2%]; OR, 0.28; 95% CI,0.06-
0.84; P = .02), and surgical complications (37 [1.8%] vs 12
[0.9%]; OR, 0.50; 95% CI, 0.25-0.93; P = .03) (Figure 2). Gra-
dation of the severity of postoperative complications is shown
in eTable 11 in the Supplement. eFigures 2 and 3 in the
Supplement show the results grouped by THA and TKA. In THA
and TKA, the highest ERAS adherence group had shorter LOS
(eFigures 2 and 3 in the Supplement) and less time to ambu-
lation and oral intake (eFigure 4 in the Supplement) in THA
and TKA (eFigures 5 and 6 in the Supplement).
Multivariable analysis of the associations with ERAS items
showed a statistically significant reduction of complications
in patients who had regional anesthesia (OR, 0.71; 95% CI, 0.53-
0.96; P = .02) and early mobilization (OR, 0.61; 95% CI, 0.45-
0.83; P = .002) (Table 2). A higher preoperative hemoglobin
value (OR, 0.84; 95% CI, 0.77-0.91; P < .001) and tranexamic
acid administration (OR, 0.66; 95% CI, 0.51-0.86; P = .002)
were associated with fewer complications, whereas blood loss
was associated with postoperative complications (OR, 1.00;
95% CI, 1.00-1.00; P < .001) (Table 2). In the multilevel study,
early mobilization was associated with decreased complica-
tions (OR, 0.60; 95% CI, 0.42-0.86; P = .005) but not regional
anesthesia (OR, 0.75; 95% CI, 0.54-1.05; P = .10) (Table 2).
Stratification of adherence to individual ERAS items by
severity groups showed that healthier patients had higher ad-
herence to ERAS (eTable 12 in the Supplement). In the ERAS
centers, patients with ASA scores of I to II experienced less in-
fection of uncertain source (1 [0.1%] vs 16 [0.5%]; OR, 0.19; 95%
CI, 0.01-0.91; P = .04), less hemorrhage (18 [0.1%] vs 104 [3.2%];
OR, 0.45; 95% CI, 0.26-0.73; P = .001), and lower median LOS









PONV prophylaxis 3842 (62.5) 2739 (60.1) 1103 (69.3)
Active prevention of unintentional hypothermia 5082 (82.7) 3734 (82.0) 1348 (84.7)
Goal-directed fluid therapy 591 (9.6) 269 (5.9) 322 (20.2)
Postoperative analgesia 5978 (97.3) 4410 (96.8) 1568 (98.5)
Postoperative glycemic control 3208 (52.2) 2258 (49.6) 950 (59.7)
Early mobilization 2166 (35.2) 984 (21.6) 1182 (74.2)
Early feeding 3953 (64.3) 2563 (56.3) 1390 (87.3)
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass
index (calculated as weight in kilograms divided by height in meters squared);
COPD, chronic obstructive pulmonary disease; ERAS, Enhanced Recovery After
Surgery; IQR, interquartile range; PONV, postoperative nausea and vomiting;
THA, total hip arthroplasty; TKA, total knee arthroplasty.
SI conversion factors: To convert albumin to grams per liter, multiply by 10;
creatinine to micromoles per liter, multiply by 88.4; hemoglobin to grams per
liter, multiply by 10.
a A complete definition list of all ERAS items was published in the protocol.17
Unless otherwise indicated, data are expressed as number (percentage) of
patients.
b Higher scores indicate severe preoperative systemic disease.
c Scores range from 1 to 9, with higher scores indicating higher level of
vulnerability.
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(4 [IQR, 3-5] vs 5 [IQR, 3-6] days; OR, 0.95; 95% CI, 0.94-0.97;
P < .001) compared with the non-ERAS centers (eFigure 7 in
the Supplement), whereas patients with ASA scores of III to IV
in the ERAS centers experienced less readmission compared
with non-ERAS centers (18 [5.2%] vs 36 [28%]; OR, 1.90; 95%
CI, 1.04-3.35; P = .04) (eFigure 8 in the Supplement). Regard-
less of belonging to a ERAS center or not, patients with ASA
scores of I to II with greater adherence to ERAS had fewer mod-
erate to severe complications (31 [3.0%] vs 79 [5.3%]; OR, 0.55;
95% CI, 0.35-0.83; P = .004) and lower median LOS (4 [IQR,
3-5] vs 5 [IQR, 4-6] days; OR, 0.97; 95% CI, 0.95-0.98; P < .001)
compared with those with less adherence to ERAS (eFigure 9
in the Supplement), whereas no difference was found be-
tween patients with ASA scores of III to IV with more or less
adherence to ERAS (eFigure 10 in the Supplement).
No significant association was found among the volume
of patients recruited, hospital LOS, and postoperative com-
plications. LOS decreased a mean of 0.0048 days due to an in-
crease in 1 patient (P = .20, associated with β regression mod-
els), whereas the increase of 1 person per center increased
the postoperative complications by 0.37% (P = .10, associ-
ated with β regression models) (Figure 3 and eFigures 11-15 in
the Supplement).
Median LOS was shorter in the ERAS group compared
with the non-ERAS group (4 [IQR, 3-5] vs 5 [IQR, 4-6] days;
P < .001). Regarding the difference by adherence quartiles,
quartile 1 presented with a median LOS of 5 (IQR, 4-6) days,
compared with 4 (IQR, 3-5) days in the highest adherence
group (OR, 0.97; 95% CI, 0.96-0.99; P < .001) (Figure 3). The
post hoc multivariable analysis of the influence of patient
characteristics and ERAS items showed a statistically signifi-
cant reduction of LOS in patients who achieved early mobili-
zation (β coefficient, −0.51; 95% CI, −0.95 to −0.06; P = .03)
and received local anesthesia (β coefficient, −1.59; 95% CI,
−2.61 to −0.57; P = .002), whereas active prevention of unin-
tentional hypothermia (β coefficient, 0.78; 95% CI, 0.30-1.26;
P = .001), epidural anesthesia (β coefficient, 1.53; 95% CI,
0.79-2.26; P < .001), and complications (β coefficient, 2.63;
95% CI, 2.00-3.25; P < .001) were associated with an increase
in LOS (eTable 13 in the Supplement). It was not necessary to
censor any P value after the multiple comparison study to
adjust the false discovery rate to 5%.
Figure 2. Postoperative Outcomes and Enhanced Recovery After Surgery (ERAS) Adherence


















(n = 1355) OR (95% CI)
Adherence Quartilea
Moderate to severe complications
270 (13.0) 116 (10.8) 150 (9.2) 144 (10.6) 0.80 (0.64-0.99) .04
Survival
143 (6.9) 74 (6.9) 76 (4.6) 59 (4.4) 0.62 (0.45-0.84) .002
—
Readmission
2073 (99.9) 1079 (100) 1636 (100) 1355 (100) —
.38
Acute kidney injury
Acute respiratory distress syndrome
33 (1.6) 24 (2.2) 34 (2.1) 27 (2.0) 1.26 (0.75-2.11)
.70
Pneumonia
31 (1.5) 10 (0.9) 22 (1.3) 18 (1.3) 0.89 (0.49-1.59)
.39
Arrhythmia
2 (0.1) 0 0 3 (0.2) 2.25 (0.34-19.36)
.16
Myocardial infarction
9 (0.4) 2 (0.2) 2 (0.1) 2 (0.1) 0.36 (0.05-1.43)
.69
Myocardial injury after noncardiac surgery
13 (0.6) 11 (1.0) 9 (0.6) 10 (0.7) 1.18 (0.50-2.72)
.85
Cardiac arrest
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LOS, median (IQR), d
106 (5.1) 49 (4.5) 45 (2.8)
12 (0.9)
0.44 (0.29-0.65)
.0337 (1.8) 9 (0.8) 21 (1.3)
4 (3-5)
0.50 (0.25-0.93)
5 (4-6) 5 (3-6) 4 (3-6) 0.97 (0.96-0.99) <.001
Patients are stratified by complications, type of complication, and other
secondary outcomes and by quartile of adherence to the ERAS protocol.
Surgical complications included all postoperative complications as defined by
protocol17 according to the standards for definitions and use of outcome
measures for clinical effectiveness research in perioperative medicine:
European Perioperative Clinical Outcome (EPCO) definitions,23 the
standardized list, definitions, and the stratification developed by the Hip
Society,24 the standarized list and definitions of the Knee Society,25 and
the Standardized Bleeding Definitions for Cardiovascular Clinical Trials.26
IQR indicates interquartile range; LOS; length of stay; and OR, odds ratio.
a Unless otherwise indicated, data are expressed as number (percentage)
of patients.
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Univariable Analysis Multivariable Analysis Multilevel Analysis
OR (95% CI)
P
Value OR (95% CI)
P
Value OR (95% CI)
P
Value
Age, mean (SD), y 68.8 (10.2) 70.8 (10.5) 1.02 (1.01-1.03) <.001 1.00 (0.99-1.02) .46 1.00 (0.99-1.02) .64
BMI, mean (SD) 30.1 (6.3) 30.0 (6.4) 1.00 (0.98-1.01) .68 0.99 (0.97-1.01) .35 0.99 (0.97-1.01) .31
Frailty score,
mean (SD)b
3.0 (1.0) 3.3 (1.1) 1.34 (1.25-1.44) <.001 1.02 (0.89-1.16) .75 1.04 (0.90-1.20) .58
ASA classificationc
ASA I 360 (92.1) 31 (7.9) NA NA NA NA NA NA
ASA II 3765 (91.0) 371 (9.0) 1.14 (0.79-1.71) .49 1.22 (0.66-2.47) .56 1.26 (0.64-2.48) .50
ASA III 1309 (83.1) 266 (16.9) 2.36 (1.62-3.55) <.001 2.14 (1.11-4.50) .03 2.23 (1.08-4.59) .03
ASA IV 31 (72.1) 12 (27.9) 4.50 (2.04-9.47) <.001 2.41 (0.68-8.02) .16 3.07 (0.84-11.22) .09
Diabetes 165 (82.1) 36 (17.9) 1.80 (1.22-2.57) .002 1.10 (0.59-1.96) .74 1.03 (0.55-1.95) .924
Heart failure 122 (77.2) 36 (22.8) 2.45 (1.65-3.54) <.001 1.35 (0.72-2.42) .33 1.40 (0.74-2.63) .30
Atrial fibrillation 344 (81.7) 77 (18.3) 1.90 (1.46-2.46) <.001 1.30 (0.86-1.93) .20 1.31 (0.86-2.00) .22
Chronic kidney
disease
273 (82.2) 59 (17.8) 1.81 (1.34-2.41) <.001 1.19 (0.72-1.91) .48 1.19 (0.71-1.99) .50
Hemoglobin level,
mean (SD), g/dL
14.1 (1.4) 13.6 (1.5) 0.79 (0.75-0.84) <.001 0.84 (0.77-0.91) <.001 0.83 (0.76-0.91) <.001
Blood loss,
mean (SD), mL
248.6 (213.7) 301.5 (263.6) 1.00 (1.00-1.00) <.001 1.00 (1.00-1.00) <.001 1.00 (1.00-1.00) <.001
Tranexamic acid
administration
4111 (90.6) 428 (9.4) 0.56 (0.47-0.66) <.001 0.66 (0.51-0.86) .002 0.75 (0.56-1.00) .048
Presurgical
education
1509 (89.4) 179 (10.6) 0.94 (0.78-1.12) .49 1.38 (0.96-1.98) .08 1.31 (0.85-2.02) .22
Presurgical
optimization
1078 (90.4) 115 (9.6) 0.94 (0.75-1.18) .62 0.86 (0.62-1.20) .39 0.94 (0.64-1.39) .76
Preoperative fasting 2683 (89.5) 314 (10.5) 0.89 (0.76-1.04) .15 1.07 (0.82-1.40) .61 1.06 (0.76-1.47) .73
Patient blood
management








2945 (88.9) 366 (11.1) 1.00 (0.85-1.17) .97 1.03 (0.80-1.32) .82 1.11 (0.83-1.47) .49
Thromboprophylaxis 5023 (88.8) 632 (11.2) 1.15 (0.85-1.58) .39 1.04 (0.68-1.67) .86 1.14 (0.70-1.87) .60
Regional anesthesia 4406 (89.6) 513 (10.4) 0.74 (0.61-0.89) .001 0.71 (0.53-0.96) .02 0.75 (0.54-1.05) .10




4506 (88.7) 576 (11.3) 1.17 (0.94-1.47) .16 1.54 (1.11-2.18) .01 1.61 (1.05-2.46) .03
Goal-directed fluid
therapy
539 (91.2) 52 (8.8) 0.76 (0.56-1.01) .07 0.98 (0.64-1.47) .97 0.87 (0.54-1.40) .57
Postoperative
analgesia
5313 (88.9) 665 (11.1) 1.28 (0.77-2.28) .37 2.40 (1.04-6.99) .07 2.28 (0.84-6.16) .11
Postoperative
glycemic control
2849 (88.8) 359 (11.2) 1.03 (0.88-1.20) .74 0.79 (0.61-1.02) .07 0.91 (0.68-1.22) .53
Early mobilization 1985 (91.6) 181 (8.4) 0.64 (0.53-0.76) <.001 0.61 (0.45-0.83) .002 0.60 (0.42-0.86) .005
Early feeding 3536 (89.5) 417 (10.5) 0.86 (0.73-1.02) .08 1.13 (0.86-1.48) .38 1.15 (0.85-1.56) .36
Analgesia
Epidural anesthesia 342 (88.1) 46 (11.9) 1.09 (0.78-1.48) .61 1.06 (0.67-1.64) .79 0.95 (0.57-1.57) .83
Regional anesthesia 836 (90.2) 91 (9.8) 0.86 (0.67-1.07) .19 1.03 (0.71-1.45) .88 0.91 (0.60-1.38,) .67
Local anesthesia 230 (91.3) 22 (8.7) 0.76 (0.47-1.16) .23 0.85 (0.36-1.72) .76 1.05 (0.45-2.47) .91
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass
index (calculated as weight in kilograms divided by square of height in meters);
IQR, interquartile range; NA, not applicable; OR, odds ratio;
PONV, postoperative nausea and vomiting.
SI conversion factors: To convert albumin to grams per liter, multiply by 10;
creatinine to micromoles per liter, multiply by 88.4; hemoglobin to grams per
liter, multiply by 10.
a Statistically significant. Unless otherwise indicated, data are expressed as
number (percentage) of patients.
b Scores range from 1 to 9, with higher scores indicating higher level of
vulnerability.
c Higher scores indicate severe preoperative systemic disease.
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Discussion
POWER2 examined the postoperative outcomes in patients
scheduled for THA or TKA and the outcomes associated with 16
evidence-based care components of an ERAS protocol in 131 cen-
ters in Spain and more than 6000 patients without limiting the
inclusion of patients to centers with an established ERAS proto-
col. Results demonstrated that the implementation of an ERAS
protocol was associated with improved postoperative outcomes.
A 2018 meta-analysis27 found that ERAS protocols were as-
sociated with a significant decrease in transfusions, compli-
cation rates, and LOS without decreasing mortality or increas-
ing the 30-day readmission rate in patients undergoing THA
or TKA. During the last decade, the clinical pathways and care
programs in THA and TKA have undergone considerable
changes in many countries influenced by the ERAS concept.28
However, in the absence of guidelines, the items that com-
prise these ERAS protocols were not clearly defined and pre-
sent a great variability in the studies performed.27 POWER2
found that the adherence to ERAS protocol in THA and TKA
was low in all patients, although it was higher and close to 70%
in self-proclaimed ERAS centers. The low adherence to ERAS
protocols may be owing to the usual barriers to the implemen-
tation of ERAS in other disciplines, such as resistance to change,
inadequate financing, lack of administration support, high
turnover, poor documentation, and lack of time,29 to which
orthopedic procedures add the lack of guidelines and the eco-
nomic pressure to achieve decreases in LOS.
An adherence of greater than 62.50% was associated with
a decrease in postoperative complications, including mild and
moderate to severe. Importantly, only some of the periopera-
tive interventions seemed to be associated with a decrease in
complications. Similarly, Khan et al12 demonstrated that the ap-
plication of an ERAS protocol based on a few components that
included a multidisciplinary strategy involving patient educa-
Figure 3. Bubble Plot of the Rate of Postoperative Complications vs Length of Stay,













































For each hospital, the plot shows the
mean percentage of adherence to the
Enhanced Recovery After Surgery
(ERAS) program (bubble color), the
mean length of hospital stay, and
percentage of patients who have
postoperative complications. The
bubble diameter indicates the
number of patients that the hospital
contributed to the study.
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tion, multimodal analgesia, standardized perioperative anes-
thesia, local anesthetic infiltration, judicious fluid administra-
tion, tranexamic acid administration, and early mobilization led
to a reduction in complications, LOS, and 30-day mortality. Khan
et al12 showed mean hospital stays of 3 days for patients in ERAS
centers, whereas in POWER2, the best results were a median of
4 days in the patients with greater adherence to ERAS. Al-
though some centers and health systems have stays of 3 or fewer
days and even perform THA and TKA as outpatient proce-
dures, the usual LOS30 is similar to that reported in POWER2.
This may be because, in Spain, patients are directly discharged
home. In contrast, postacute care is typically available and cov-
ered by insurance companies in the United States and in other
countries, making it easy for hospitals to discharge patients to
rehabilitation facilities or to other intermediate centers.31
POWER2 found no association between comorbidities or
frailty and complications, although patients with an ASA physi-
cal status score of III had more complications. We found that
in the ERAS centers and in the group with greater ERAS ad-
herence, there were more healthy patients. This finding could
explain the best results in these groups. In fact, although the
ERAS programs in THA and TKA have been proven safe and
beneficial for most patients, we have found that in high-risk
patients (ASA scores of III-IV), the application of ERAS, even
in the highest adherence quartiles, did not result in better out-
comes, although there were fewer readmissions.12
In patients undergoing major orthopedic surgical proce-
dures, preoperative anemia, perioperative bleeding, and a lib-
eral transfusion policy are the main risk factors for requiring
an RBCT,32 which increases complications and LOS.33,34 Yang
et al35 showed that in patients undergoing TKA, tranexamic acid
administration reduced blood loss and the need for RBCT. Simi-
larly, we found that lower preoperative hemoglobin values and
intraoperative bleeding were associated with an increase in
complications, whereas the administration of tranexamic acid
was associated with a decrease. Avoiding anemia, improving
tolerance to anemia, and avoiding bleeding and RBCT are the
pillars of patient blood management programs.36 Surpris-
ingly, the ERAS patient blood management item included in
POWER2 has not been associated with better outcomes. In our
opinion, many centers may apply the patient blood manage-
ment measures without recognizing them as such.
It is not surprising that good analgesic control leads to early
mobilization, and accomplishment of these items was associ-
ated with improved outcomes. Early mobilization in the first
24 hours after THA or TKA had been shown to be effective in
reducing LOS, although it had not been associated with a de-
crease in complications.37 Nevertheless, in POWER2, early mo-
bilization was associated with fewer complications and shorter
LOS. Conversely, epidural anesthesia was associated with a
greater than 1-day increase in hospital LOS.
Early mobilization is considered a cornerstone in ERAS
pathways and is strongly recommended as part of ERAS guide-
lines in many surgical disciplines.8 ERAS Society guidelines rec-
ommend that patients be mobilized as soon as possible after
surgery.14 Chua et al38 found that for patients undergoing THA,
shorter time to mobilization was associated with hospital site
and the absence of acute complications. For patients under-
going TKA, shorter time to mobilization was associated with
hospital site and absence of donor blood transfusion.38 These
outcomes indicate that the patient who has complications can-
not move early, and delays in mobilization could be taken as
an alarm signal for possible complications. However, the de-
lay until mobilization can also be related to the institution and
local protocols, because certain hospitals encourage early pa-
tient mobilization, whereas others do not.
Strengths and Limitations
POWER2 had several strengths compared with other studies.
This was a prospective study, with a case report form designed
specifically for the study and with a short recruitment period
of 2 months. We also included a large number of centers. Other
studies have had years-long durations.34 Khan et al12 showed
that the application of an ERAS program improved outcomes
in a single center and in a long period of 7 years; the changes
produced in such long periods decrease patient comparability.
On the other hand, some of the studies with the highest num-
ber of cases were registers in national databases, in which it is
assumed that all patients were treated with an ERAS protocol,
but in which the adherence was not analyzed. We have in-
cluded self-described ERAS centers and non-ERAS centers, and
we have analyzed the variables that make up the ERAS proto-
col in all the centers, unlike the studies based on databases or
the before-and-after studies. Moreover, the inclusion of con-
secutive, nonselected patients from 131 different centers with-
out any selection bias increases the internal validity of our study.
In addition, there were few losses of follow-up.
Our study has certain limitations. It was observational,
which means that we can only obtain associations. Second, as
previously mentioned, early mobilization can act as a con-
founding factor; because patients with complications could not
fulfill this item, whether mobilization is an exposure factor or
an outcome is debatable. We believe that it must be treated as
both, and that all patients should be encouraged to move as
soon as possible after surgery, because this has been shown
to improve postoperative outcomes.39 Third, we chose the in-
dividual ERAS items based on expert recommendations15; if
we had selected other items, the results might be different. On
the other hand, the patients in the ERAS group probably cor-
responded to more specialized centers and were healthier com-
pared with patients in non-ERAS centers, which could ex-
plain why they had better outcomes.
Conclusions
This study found that ERAS protocols in THA and TKA do not
appear to be applied in daily clinical practice, even in self-
proclaimed ERAS centers, even though a greater adherence to
ERAS improves postoperative outcomes. An effective path-
way for THA and TKA consists of regional or local analgesia,
anemia and bleeding management, and early mobilization as
the basis of the care trajectory. Consequently, our findings sug-
gest that the focus should be on these essential elements of
care rather than on expanding adherence to the other, less evi-
dence-based components in most ERAS protocols.
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Surgery). Hospital Universitario Dr Peset,
Valencia: Jorge Bellver (PI), Joana Baldó, Cristina
Álvarez, Concepción Barrachina, José M. Castillo
(data validator), José Higueras, Estefanía
Martínez-González, María J. Molina, Leticia
Narváez, Oscar Ramírez, Fernando Rauer, María T.
Richart, Amparo S. de-Merás, Cyntia
Sánchez-Martín, and Luisa Sapena (Department of
Anesthesia). Hospital Universitario de Cáceres:
Juan M. Redondo-Enríquez (PI and data validator),
Francisco B. Amador-Penco, Antonio
Barba-Orejudo, Inés de-Tena-Rocha, Marta
Donoso-Domínguez, Laura Fuentes-Coco,
Fernando García-Montoto-Pérez, Yasmina
González-Marín, Luis G. Smith-Vielma, Álvaro
San-Antonio-Gil, Pedro Fernández-Nuñez, and José
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I. Hermoso-Martínez (Department of Anesthesia).
Hospital Universitario De Cabueñes: Javier
Albaladejo-Magdalena (PI and data validator), Ana
Rodríguez-Morala and Javier Carbayo-Lázaro
(Department of Anesthesia). Clínica Santa Cristina,
Albacete: Ubaldo Vicente-Gutiérrez (PI and data
validator) (Department of Anesthesia), Jésus
Martínez-Casrtroverde and Eduardo
Rodriguez-Vellando-Rubio (Department of
Orthopedic Surgery). Clinica HLA Vistahermosa:
Jesús J. Mas Martinez (PI and data validator) and
Javier Sanz-Reig (PI) (Department of Orthopedic
Surgery); Enrique Cardenas-Alegría (Department of
Anesthesia). Complejo Asistencial De Zamora:
Ana M. García-Sánchez (PI and data validator),
María Gómez-Fernández, Ana M. Lafuente-Lera,
and Gema Martínez-Ragüés (PI) (Department of
Anesthesia); Gonzalo Humada-Álvarez and Camino
Román-Dopazo (Department of Orthopedic
Surgery). Complejo Hospitalario Universitario de
Badajoz: Maria D. Torrado-Criado (PI and data
validator), Laura Caperote-Anchez, Juan R.
Caro-González, Francisco S. Castaño-García, Ana
Marín-Moreno, Gema Montero-Mejías, and Cristina
Pinilla-Silva (Department of Anesthesia); Rafael
Lorente-Moreno (data validator) (Department of
Orthopedic Surgery). Complejo Hospitalario
Universitario De Vigo–Eoxi Vigo: Lidia
Padin-Barreiro (PI and data validator), María I. Vidal
Lopo, Iván Areán-González, María A. Gil-Campelo,
Pedro Martínez-Guitián, José R. Reparaz-Andrade,
and Gerardo Baños-Rodríguez (Department of
Anesthesia). Hospital De La Cruz Roja, Gijón:
Nicolás Rodríguez-García (PI and data validator)
(Department of Anesthesia); Daniel
García-Rodríguez (PI) (Department of Orthopedic
Surgery). Hospital Universitario de Gran Canaria
Doctor Negrín: Ángel Becerra-Bolaños (PI and data
validator), Aurelio Rodríguez-Pérez, Iván M.
Beirutti-Ruiz, Carmen Arachelly-Focaccio-Tejada,
Julio Gómez-Marrero, Leonardo Cabrera-Ramírez,
and Mutaz Mourad-Mohamed (Department of
Anesthesia). Hospital Don Benito Vilanueva:
Marta López-Marqués (PI), María P.
Rodríguez-Chaparro, Enrique Del-Cojo-Peces (data
validator) (Department of Anesthesia). Hospital El
Bierzo: Sergio Núñez-Moreno (PI), Sarai
Suárez-Fernández, and Irene
Ruperez-San-Emeterio (data validator)
(Department of Anesthesia); Marta Novoa-Cortiñas
and Alicia Sánchez-Parada (Department of
Orthopedic Surgery). Hospital De
Galdakao-Usansolo: Pilar Pérez-Sánchez (PI and
data validator), Claudia Velasco-Oficialdegui,
Fernado Jáuregui-Beraza, Pilar Macua-Biurrun,
Raquel Malanda-Callejo, and Aizpea
Aguirrezabal-Juaristi (Department of Anesthesia).
Hospital General de Granollers: Germán
Moreno-Aguilar (PI and data validator), Carmen
Sanabria-Pico, and Regina Sopena-García
(Department of Anesthesia). Hospital General
Universitario Gregorio Marañón, Madrid: Roberto
de-Diego-Fernández (PI), Alba Burgos-Santamaría,




Ana G. Pizarro-Calderón, Mercedes Power-Esteban,
Usamah Rabih-Kanji, Olalla Varela-García, Juan M.
de-Vicente-Peña, and Santiago García-Hernández
(Department of Anesthesia). Hospital
Universitario de Guadalajara: Mercedes
Cabellos-Olivares (PI), Laura M. Martínez-Meco (PI),
and José R. Rodríguez-Fraile (data validator)
(Department of Anesthesia). Hospital
Universitario 12 de Octubre, Madrid: Álvaro
Ramiro-Ruiz (PI and data validator), Pablo
García-Pimentel, Sergio García-Pérez, Noelia
González-Rabadán, Adrián Martínez-López, Teresa
Martínez-Marivela, Belinda Montalbán-Moreno,
Noelia Zurera-Plaza, Rubén Salas-Rodríguez,
Claudia Sarrais-Polo, and Claudia Olea-Vielba
(Department of Anesthesia). Hospital d’Igualada:
Laura Perelló-i-Cerdà (PI), Josep M. Bausili-Pons
(data validator), Ana B. Pedregosa-Sanz, Ana M.
Pedrero, and Joaquim Sabater-Recolons
(Department of Anesthesia). Hospital
Universitario Infanta Leonor, Madrid: Javier
Ripollés-Melchor (PI), Ane Abad-Motos (PI), Beatriz
Nozal-Mateo, Rut Salvachua-Fernández, Alfredo
Abad-Gurumeta, Elena Sáez-Ruiz, Eugenio
Martínez-Hurtado (data validator), Elena
Lucena-de-Pablo, Elena Nieto-Moreno, and Norma
Aracil-Escoda (Department of Anesthesia); Oliver
Marín-Peña (PI) and David Murillo-Vizuete
(Department of Orthopedic Surgery); Elena
Sánchez-Pérez (Nursery). Hospital General
Universitario de Castellón: José M.
España-Pamplona (PI and data validator), Laura
Jordá-Sanz, María Vellida-Vilarroig, and María I.
De-Miguel-Cabrera (Department of Anesthesia).
Hospital Universitario Clínico San Carlos, Madrid:
Rubén Sánchez-Martín (PI and data validator),
Jesús Hurtado-Martín, Jhon López-Hormiga, Julián
A. Vargas-Ardila, Karina Martins-Cruz, Lourdes
Durán-Giménez-Rico, and Rosalía Navarro-Pérez
(Department of Anesthesia). Fundacio Salut
Emporda – Hospital De Figueres: Manel
Roig-Gasull (PI and data validator), María del Mar
Piazuelo, and Carlos Salazar-Zamorano
(Department of Anesthesia). Consorcio Hospital
General Universitario de Valencia: Juan C.
Catalá-Bauset (PI), Rafael Colomina-Rodriguez
(data validator), Lorenzo Hernádez-Ferrando, Pablo
Rodríguez-Gimillo, Raquel Moratalla-García, Elena
Biosca-Pérez, María Olivas-Dols, Lucas
Rovira-Soriano, Rubén Rubio-Haro, Francisco
Gil-Chaves, Francisco Jara-García, and Jorge
Ubeda-Pascual (Department of Anesthesia).
Hospital Manises: Aurora Moreno-Gazquez (PI),
Raquel Viñedo-Lillo, Óscar Torres-Rico, and Vicente
R. Chisbert-Cuenca (Department of Anesthesia).
Hospital Municipal de Badalona: Eduard
Siles-Fuentes (PI), Ester Mora-Solé, and Javier
González-López (data validator) (Department of
Orthopedic Surgery). Hospital Quirón de Marbella
y Hospital Quirón Campo de Gibraltar: Blas
Rodriguez-Gil (PI and data validator), Belén
Castillo-Cardona, Raimundo Escudero-Concha,
Mathieu Juvin-Bouvier (PI), and José
Romero-Aguilar (Department of Anesthesia).
Hospital Quirónsalud Torrevieja: Andrej Balík
(PI and data validator), Noelia Ruiz-Vera, Julio P.
Vinuesa-Núñez, and Ana B. Tovar-López
(Department of Anesthesia). Hospital
Universitario San Agustín, Avilés: Diana
de-la-Uz-Díaz (PI), Paz Alonso-Pérez (data
validator), Juan R. Artamendi-Suárez, Jesús
Bujarrabal-Martínez, Lorena España-Fuente, Ángel
Gómez-Martín, María J. González-Miranda,
Covadonga Gutiérrez-González, Beatriz
Laserna-Cocina, Marta López-Pérez, Andrea
Manzano-Patallo, Gabriel Mella-Pérez, Rosa E.
Méndez-Redondo, Marina Rodríguez-Rodríguez,
Cristina M. Rodríguez-Rodríguez, Laura
Morante-Carrión, and Pablo de-la-Rica-Fernández
(Department of Anesthesia). Hospital Universitari
Mútua Terrassa: Marga Novellas-Canosa (PI)
(Department of Anesthesia); Francesc
Anglès-Crespo (PI and data validator) (Department
of Orthopedic Surgery). Hospital Universitario
Severo Ochoa, Leganés: Vanesa Blázquez-Calvo
(PI), Luis Fuentetaja-Martín-Portugués, Patricia
Lloreda-Herradón, Adela Gardeta-Pallarés, Soraya
Gholamian-Ovejero, Raquel González-Velasco,
Adolfo Ramos-Luengo, Marta Vicente-Orgaz,
Purificación Sánchez-Zamora, and Gema
Fraga-Casais (data validator) (Department of
Anestesia); Hilario Miguez-Pérez (Department of
Orthopedic Surgery). Hospital Universitari i
Politècnico la Fe de Valencia: Lucia
Cabezudo-de-la-Muela (PI and data validator),
Beatriz Castel-González, Daniel Martínez-Català,
and María D. Ruiz-Boluda (Department of
Anesthesia). Hospital Clínico Universitario Lozano
Blesa de Zaragoza: Aurora Callau-Calvo (PI),
Patricia García-Consuegra, and Javier Longás-Vailén
(data validator) (Department of Anesthesia); José
M. Ramírez-Rodríguez (Department of General
Surgery). Hospital de Mataró: Marta
Villanova-Baraza (PI and data validator), Roser
Torruella-Turró, Raquel Algilaga-Segovia, Isabel
Fábregas-Blanco, Maria Farolera-Bonamusa, Elisa
Reñé-de-Antonio, Alexia Nebot-Galindo, and
Cassandra Gimeno-Grauwinkel (Department of
Anesthesia). Hospital Medina del Campo: María T.
Fernández-Martín (PI and data validator), Juan C.
Álvarez-López, Beatriz Cano-Hernández, and
Christian Bravo-Ovadia (Department of Anesthesia).
Hospital Universitario de Torrejón: Elena
García-Fernández (PI and data validator), Sergio
Lorrio-Palomino, Jesús Recio-Pérez, and José M.
Requena (Department of Anesthesia). Hospital
Nuestra Señora del Prado, Talavera de la Reina:
Pablo Gimeno-Fernández (PI and data validator),
José L. Gómez-Agraz, Carla Iglesias-Morales,
Patricia Ordoñez-Díaz, Hilda L. Quispe-Melendez,
Joselvy Rodríguez-Pinto, Patricia Sabin-Gutierrez,
Yolanda Sarabia-Mora, and Elzbieta Stasiak-Pikula
(Department of Anesthesia). Hospital
Universitario Puerta de Hierro Majadahonda:
Lucía Ormaechea-Bolado (PI and data validator),
Guillermo Arespacochaga-Ramos, Marina
Carmona-Prieto, Fernando Herva-Pintor, Ana
Lacaba-Mazarío, and Javier Martínez-Caridad
(Department of Anesthesia); Teresa Beteta-Robles,
Beatriz Fernández-Maza, Marta Isabel Sanz-Pérez,
and Marta Yáguez-Hernández (Department of
Orthopedic Surgery). Quiron Teknon Barcelona:
Adriana Bataller-Bassols (PI and data validator),
Milen Bonev-Bonev, Amparo Gómez-Mantecon,
Karen Salazar-Loaiza, and Josep Rodiera-Olivé
(Department of Anesthesia); Diego
Collado-Gastalver, Rafael González-Adrio, Ferran
Montserrat-Ramon, David Roca-Romalde, and
Miquel Sales-Pérez (Department of Orthopedic
Surgery). Hospital Ruber Internacional. Madrid:
Uxío García-Aldao (PI), Judit Benítez, Pilar Bernad,
Álvaro Elícegui, Daciano Gaona, Isabel Gómez,
Álvaro de-la-Vega, Juan P. Von-Walter, and Javier
de-Benito (data validator) (Department of
Anesthesia). Hospital Universitari de Santa Maria,
Lleida: Jordi Colomina-Morales (PI and data
validator), Isabel Parada-Avendaño (Department of
Orthopedic Surgery); Reis Drudis-Morell (PI) and
Montserrat Torra-Riera (Department of Anesthesia).
Hospital de Zumarraga, OSI Goierri Alto Urola:
Sandra L. Muñoz-Pérez (PI and data validator), Iñaki
Roa-Martínez, Angel Beriain-Arcelus, Maitane
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Rubio–de-Jesús, and Marco Amambal-Altamirano
(Department of Anesthesia). Hospital
Universitario Lucus Augusti: María
Bermúdez-López (PI and data validator), María
López-Rodríguez, Carlos Villagrán-Marín, Gloria
Prado-Núñez, and Patricia Vázquez- Dopazo
(Department of Anesthesia). Complejo Asistencial
Universitario de León: Cristina García-Pérez
(PI and data validator), Sergio Marcos-Contreras,
Javier Ferrero-de-Paz, and Diana Fernández-García
(Department of Anesthesia). Servicio Navarro de
Salud-Osasunbidea, Pamplona, Navarra: José A.
García-Erce (PI) (Blood and Tissue Bank). Hospital
MAZ Zaragoza: Clara Marín-Zaldívar (PI and data
validator) and Amagoia
Fernández-de-Gamarra-Goiricelaya (Department of
Anesthesia); Julian C Segura-Mata (PI), Juan F
Blanco-Gómez, Carlos M Enseñat-Schulte, Silvia
Gomez-Gomez, Maria Llorens-Eizaguerri, Lucia
Lopez-Sagasta, and Jesus Rivas-Felice (Department
of Orthopedic Surgery). Hospital Universitario de
Vic: Jordi Serrat-Puyol (PI and data validator),
Teresa Planella-Rius, and Julio Roza-Baglietto
(Department of Anesthesia); Laia Boadas-Gironés
and Daniel Estevez-Sabogal (Department of
Orthopedic Surgery). Hospital Universitario
Fundación Jiménez Díaz, Madrid: Patricio J
Amaro-Soto, Philipp Peter-Granacher, Raquel
García-Ortega, Raquel Iglesias-Guitian, Fernando
López-Arias, and Soledad Bellas-Cotan (PI and data
validator). Hospital Virgen de los Lirios, Alcoy:
José Luis Jover-Pinillos (PI), Vicente Climent-Peris,
and José Pedro García-Belmonte (data validator).
Hospital Universitario Príncipe de Asturias,
Alcalá de Henares: Carmen Demartini-Foj (PI and
data validator), Fernando Poveda-Sáenz, and
Francisco Barrios (Department of Anesthesia).
Hospital Universitario Infanta Elena, Valdemoro:
Rubén Casans-Frances (PI and data validator), Thais
Martinez-Mejia, Enrique Golderos, and Elena
Del-Hierro (Department of Anesthesia); Francisco J.
Cervero, Elena Galvez, Elena Villarrubia, Rodrigo
Anton, Pablo Vadillo, Daniel López-Dorado, Raquel
Serrano, Rocío Mascaraque, and Hugo Garlito
(Department of Orthopedic Surgery). Hospital del
Poniente, El Ejido: Miguel Martínez-Espinosa
(PI and data validator) and Alberto Albert-Ullibarri
(Department of Orthopedic Surgery). Hospital
Universitario Virgen del Rocío: Juan
Sánchez-Peña, Maria de los Ángeles Luengo-Pastor,
Manuel Sariego-Ortiz, Jesús Fernández-López, Juan
Miguel Pérez-de-Tudela, Juan Francisco
Gómez-Curiel, Manuel Agustín Castro-Marín, Alvaro
Sosa-Orts, Francisco Manzano-Capitán, Rosana
Guerrero-Domínguez, Francisco Bullón-Barrera,
Inmaculada Jimeno-Puche, Francisco
Polonio-Enríquez, Lucia Romero-Escalante, Ana
Martínez-Saniger, Concepción Martínez-Torres, and
Ignacio Jiménez-López (PI and data validator)
(Department of Anesthesia).
Additional Contributions: Julián Álvarez Escudero,
MD, PhD, President of the Spanish Society of
Anesthesiology and Critical Care (SEDAR) provided
a noncompensated prerecruitment announcement
of the study on the SEDAR website. Alejandro Bona
Enguita, BS, served as the POWER2 website
webmaster. No financial compensation was
provided.
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